Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Clinical trial NCT02537600 · COMPLETED

Trial details

NCT number: NCT02537600
Sponsor: Center Eugene Marquis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2015-12-01
Primary completion: 2019-11-06
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.